Genscript Biotech Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNNSF research report →
Companywww.genscript.com
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in North America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. It operates through four segments: Life Science Services and Products, Biologics Development Services, Industrial Synthetic Biology Products, and Cell Therapy. The Life Science Services and Products segment provides research services in various categories, including gene synthesis and molecular cloning, oligonucleotide synthesis, protein engineering, peptide synthesis, antibody development, molecular diagnostics tools, and genome editing materials for use in basic biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and food industry.
- CEO
- Weihui Shao
- IPO
- 2017
- Employees
- 5,568
- HQ
- Nanjing, CN
Price Chart
Valuation
- Market Cap
- $3.77B
- P/E
- -6.85
- P/S
- 3.81
- P/B
- 0.92
- EV/EBITDA
- 12.62
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 57.65%
- Op Margin
- 26.60%
- Net Margin
- -55.53%
- ROE
- -12.72%
- ROIC
- 5.55%
Growth & Income
- Revenue
- $960.95M · 61.64%
- Net Income
- $-533,618,209 · -118.02%
- EPS
- $-0.25 · -117.86%
- Op Income
- $255.62M
- FCF YoY
- 434.41%
Performance & Tape
- 52W High
- $2.42
- 52W Low
- $1.30
- 50D MA
- $1.50
- 200D MA
- $1.90
- Beta
- 0.96
- Avg Volume
- 849
Get TickerSpark's AI analysis on GNNSF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GNNSF Coverage
We haven't published any research on GNNSF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GNNSF Report →